Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy.
J Oncol. 2022 Jan 12;2022:3477148. doi: 10.1155/2022/3477148. eCollection 2022.
J Oncol. 2022.
PMID: 35069733
Free PMC article.